Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 86
Filter
1.
Clin Epigenetics ; 16(1): 61, 2024 May 07.
Article in English | MEDLINE | ID: mdl-38715048

ABSTRACT

BACKGROUND: Diabetes in pregnancy is associated with increased risk of long-term metabolic disease in the offspring, potentially mediated by in utero epigenetic variation. Previously, we identified multiple differentially methylated single CpG sites in offspring of women with gestational diabetes mellitus (GDM), but whether stretches of differentially methylated regions (DMRs) can also be identified in adolescent GDM offspring is unknown. Here, we investigate which DNA regions in adolescent offspring are differentially methylated in blood by exposure to diabetes in pregnancy. The secondary aim was to characterize the RNA expression of the identified DMR, which contained the nc886 non-coding RNA. METHODS: To identify DMRs, we employed the bump hunter method in samples from young (9-16 yr, n = 92) offspring of women with GDM (O-GDM) and control offspring (n = 94). Validation by pyrosequencing was performed in an adult offspring cohort (age 28-33 years) consisting of O-GDM (n = 82), offspring exposed to maternal type 1 diabetes (O-T1D, n = 67) and control offspring (O-BP, n = 57). RNA-expression was measured using RT-qPCR in subcutaneous adipose tissue and skeletal muscle. RESULTS: One significant DMR represented by 10 CpGs with a bimodal methylation pattern was identified, located in the nc886/VTRNA2-1 non-coding RNA gene. Low methylation status across all CpGs of the nc886 in the young offspring was associated with maternal GDM. While low methylation degree in adult offspring in blood, adipose tissue, and skeletal muscle was not associated with maternal GDM, adipose tissue nc886 expression was increased in O-GDM compared to O-BP, but not in O-T1D. In addition, adipose tissue nc886 expression levels were positively associated with maternal pre-pregnancy BMI (p = 0.006), but not with the offspring's own adiposity. CONCLUSIONS: Our results highlight that nc886 is a metastable epiallele, whose methylation in young offspring is negatively correlated with maternal obesity and GDM status. The physiological effect of nc886 may be more important in adipose tissue than in skeletal muscle. Further research should aim to investigate how nc886 regulation in adipose tissue by exposure to GDM may contribute to development of metabolic disease.


Subject(s)
Adipose Tissue , DNA Methylation , Diabetes, Gestational , Epigenesis, Genetic , Muscle, Skeletal , Prenatal Exposure Delayed Effects , Humans , Pregnancy , Female , Diabetes, Gestational/genetics , Epigenesis, Genetic/genetics , Adult , DNA Methylation/genetics , Muscle, Skeletal/metabolism , Adolescent , Adipose Tissue/metabolism , Male , Prenatal Exposure Delayed Effects/genetics , Child , Diabetes Mellitus, Type 1/genetics , RNA, Untranslated/genetics , RNA, Untranslated/blood , RNA, Long Noncoding/genetics , CpG Islands/genetics
2.
Clin Transl Oncol ; 26(6): 1497-1507, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38227115

ABSTRACT

BACKGROUND: In view of discordance consisting in different reports, a meta-analysis was conducted to comprehensively evaluate the diagnostic efficacy of exosomal noncoding RNAs (ncRNAs) in blood and urine in the detection of bladder cancer. METHODS: Eligible studies were acquired by systematic retrieval through PubMed, Cochrane Library, and Embase. The pooled diagnostic efficacy was appraised by reckoning the area under the summary receiver operating characteristic (SROC) curve. The latent sources of heterogeneity were probed by subgroup analyses and meta-regression. STATA 12.0, Meta-DiSc 1.4, and RevMan 5.3 were applied to carry out all statistical analyses and plots. RESULTS: A total of 46 studies from 15 articles comprising 2622 controls and 3015 bladder cancer patients were included in our meta-analysis. Exosomal ncRNAs in blood and urine represented relatively satisfactory diagnostic efficacy in detecting bladder cancer, with a pooled sensitivity of 0.75, a specificity of 0.79, and an area under the SROC curve (AUC) of 0.84. Exosomal microRNAs (miRNAs) exhibited better diagnostic value with a pooled AUC of 0.91 than that of exosomal long noncoding RNAs (lncRNAs). To some extent, the heterogeneity among studies was induced by exosomal ncRNA types (miRNA or lncRNA), exosomal ncRNA profiling (single- or multiple-ncRNA), sample size, specimen types, and ethnicity. CONCLUSION: Exosomal ncRNAs in blood and urine may play a vital role in diagnosing bladder cancer as prospective noninvasive biomarkers; nonetheless, their clinical performance needs to be confirmed by further massive proactive researches.


Subject(s)
Biomarkers, Tumor , Exosomes , Urinary Bladder Neoplasms , Urinary Bladder Neoplasms/genetics , Urinary Bladder Neoplasms/diagnosis , Urinary Bladder Neoplasms/blood , Urinary Bladder Neoplasms/urine , Humans , Exosomes/genetics , Biomarkers, Tumor/genetics , Biomarkers, Tumor/blood , Biomarkers, Tumor/urine , RNA, Long Noncoding/genetics , RNA, Long Noncoding/urine , RNA, Long Noncoding/blood , RNA, Untranslated/genetics , RNA, Untranslated/blood , RNA, Untranslated/urine , MicroRNAs/urine , MicroRNAs/blood , MicroRNAs/genetics , ROC Curve
3.
Bioengineered ; 13(2): 4039-4050, 2022 02.
Article in English | MEDLINE | ID: mdl-35129049

ABSTRACT

The occurrence of fungal infection seriously affects the survival and life quality of transplanted patients. The accurate diagnosis is of particular importance in the early stage of infection. To develop a novel diagnostic method for this kind of patient, we established a post-transplant immunosuppressed mice model with fungus inoculation and collected their peripheral blood at specific time points after infection. After screening by microarray, differentially expressed miRNAs and lncRNAs were selected and homologously analyzed with those of human beings from the gene database. These miRNAs and lncRNAs candidates were validated by qRT-PCR in peripheral blood samples from transplanted patients. We found that, compared with normal transplanted patients, the levels of miR-215 and miR-let-7 c were up-regulated in the plasma of patients with fungal infection (P < 0.01), while levels of miR-154, miR-193a, NR_027669.1, and NR_036506.1 were down-regulated in their peripheral blood mononuclear cells (P < 0.01). Principal component analysis shows that the expression pattern of the above RNAs was different between the two groups. A 6-noncoding-RNA detection panel was established by the support vector machine analysis, whose area under the ROC curve was 0.927. The accuracy, precision, sensitivity, and specificity of this model were 0.928, 0.919, 0.944, and 0.910, respectively. Though our detection panel has excellent diagnostic efficacy, its clinical application value still needs to be further confirmed by multi-center prospective clinical trials.


Subject(s)
Mycoses , RNA, Untranslated , Transplantation/adverse effects , Animals , Disease Models, Animal , Humans , Immunocompromised Host , Male , Mice , Mice, Inbred C57BL , Mycoses/diagnosis , Mycoses/genetics , Principal Component Analysis , RNA, Untranslated/blood , RNA, Untranslated/genetics
4.
Clin. transl. oncol. (Print) ; 23(11): 2220-2236, nov. 2021. ilus
Article in English | IBECS | ID: ibc-223418

ABSTRACT

Colorectal cancer (CRC) is one of the most common malignant tumors, and a large number of patients are diagnosed and die every year. Due to the lack of appropriate diagnosis, prediction and treatment, early diagnosis rate of CRC is low and the prognosis is poor. Studies have found that abnormally expressed non-coding RNAs (ncRNAs) (including microRNAs (miRNAs), circular RNAs (circRNAs) and long non-coding RNAs (lncRNAs),etc.) play an important regulatory role in the occurrence and development of CRC. Some studies have shown that they are stable in the blood and can be detected repeatedly. They are expected to be non-invasive biomarkers for early diagnosis, prognosis evaluation, and prediction of drug sensitivity of CRC, as well as potential applications in the treatment of CRC (AU)


Subject(s)
Humans , Colorectal Neoplasms/blood , Biomarkers, Tumor/blood , RNA, Untranslated/blood , Colorectal Neoplasms/drug therapy , Colorectal Neoplasms/genetics , Early Detection of Cancer , MicroRNAs/blood , Prognosis , Cell-Free Nucleic Acids , RNA, Long Noncoding/blood
5.
Clin Transl Oncol ; 23(11): 2220-2236, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34275108

ABSTRACT

Colorectal cancer (CRC) is one of the most common malignant tumors, and a large number of patients are diagnosed and die every year. Due to the lack of appropriate diagnosis, prediction and treatment, early diagnosis rate of CRC is low and the prognosis is poor. Studies have found that abnormally expressed non-coding RNAs (ncRNAs) (including microRNAs (miRNAs), circular RNAs (circRNAs) and long non-coding RNAs (lncRNAs),etc.) play an important regulatory role in the occurrence and development of CRC. Some studies have shown that they are stable in the blood and can be detected repeatedly. They are expected to be non-invasive biomarkers for early diagnosis, prognosis evaluation, and prediction of drug sensitivity of CRC, as well as potential applications in the treatment of CRC.


Subject(s)
Biomarkers, Tumor/blood , Colorectal Neoplasms/blood , RNA, Untranslated/blood , Colorectal Neoplasms/drug therapy , Colorectal Neoplasms/genetics , Early Detection of Cancer/statistics & numerical data , Humans , MicroRNAs/blood , Prognosis , RNA, Circular/blood , RNA, Long Noncoding/blood
6.
Methods Mol Biol ; 2300: 143-164, 2021.
Article in English | MEDLINE | ID: mdl-33792879

ABSTRACT

Non-coding RNAs participate in most cellular processes and play a causative role in several diseases. In addition to their relevance as targets or tools for therapy, ncRNAs have been extensively detected in body fluids supporting their role as easily accessible and minimally invasive biomarkers. However, the precise measurement of circulating ncRNAs remains challenging due to their low abundance and the heterogeneity of the ncRNA population (size, polyadenylation status, circular forms). Microarrays constitute a very powerful method to analyze the expression level and the splicing pattern of circulating ncRNAs since they preserve sample integrity (no need to remove globin or rRNA) and allow precise quantification of low-abundance transcripts (no limitation by read depth). This chapter describes the protocols used in our lab to extract and purify total RNAs from PAXgene RNA Blood Tubes and to perform RNA labeling and hybridization on the Clariom™ D microarrays from Affymetrix.


Subject(s)
Exome Sequencing/methods , RNA, Untranslated/blood , Blood Specimen Collection , Gene Expression Profiling , Humans , Oligonucleotide Array Sequence Analysis/methods , RNA, Untranslated/chemistry , RNA, Untranslated/genetics , Staining and Labeling
7.
Methods Mol Biol ; 2284: 445-455, 2021.
Article in English | MEDLINE | ID: mdl-33835456

ABSTRACT

Noninvasive biomarkers are required for addressing crucial clinical needs. The ideal biomarker should be easily accessible and provide a unique characteristic for a healthy status or a pathological condition. In the last years, microRNAs (miRNAs) have been proposed as promising tissue-based biomarkers for several diseases such as cancer and cardiovascular diseases. Recently, miRNAs have shown great potential as novel noninvasive biomarkers, due to their high stability in human body fluids such as serum, plasma, and urine. Furthermore, many other noncoding RNAs (ncRNAs) such as long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs) have shown to be novel biomarkers as well. The aim of this exciting research field is to offer novel tools, allowing translational scientists to develop new strategies for diagnosis, screening, and monitoring of diseases. In this book chapter, the miRandola database and its applications will be introduced. The database offers the possibility to explore information on ncRNAs as noninvasive biomarkers, manually extracted from scientific literature and public available resources.


Subject(s)
Biomarkers , Databases, Genetic , MicroRNAs/analysis , Translational Research, Biomedical/methods , Biomarkers/analysis , Biomarkers/blood , Biomarkers/urine , Body Fluids/chemistry , Body Fluids/metabolism , Cardiovascular Diseases/blood , Cardiovascular Diseases/genetics , Cardiovascular Diseases/urine , Databases, Genetic/statistics & numerical data , Disease/genetics , Humans , MicroRNAs/blood , MicroRNAs/urine , Monitoring, Physiologic/methods , RNA, Circular/analysis , RNA, Circular/blood , RNA, Circular/urine , RNA, Long Noncoding/analysis , RNA, Long Noncoding/blood , RNA, Long Noncoding/urine , RNA, Untranslated/analysis , RNA, Untranslated/blood , RNA, Untranslated/urine
8.
J Stroke Cerebrovasc Dis ; 30(6): 105762, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33813080

ABSTRACT

BACKGROUND: Early diagnosis of intracranial aneurysm (IA) is arduous in the current situation, and no biomarker is available for the screening of IA. We here systematically evaluate the diagnostic value of circulating non-coding RNA (ncRNA) for the diagnosis of IA. METHODS: We searched PubMed, Web of Science, Embase, Scopus and Cochrane Library databases from inception to June 2020. We included studies that investigated the diagnostic performance of circulating ncRNAs for the diagnosis of IA. We performed Random-effect meta-analyses for the diagnostic test accuracy to calculate pooled estimates. Subgroup analyses and sensitivity analyses were conducted to explore the source of heterogeneity. RESULTS: Thirteen studies, including 1,105 patients and 28 ncRNAs, were included. The pooled sensitivity and specificity were 0.80 (95% confidence interval [CI], 0.76-0.83) and 0.80 (95% CI, 0.76-0.84), respectively, and the area under the hierarchical summary receiver operating characteristic curve was 0.87 (95% CI, 0.84-0.89). The pooled positive and negative likelihood ratios were 3.97 (95% CI, 3.17-4.98) and 0.25 (95% CI, 0.21-0.31), corresponding with a diagnostic odds ratio of 15.63 (95% CI, 10.41-23.47). Subgroup analyses revealed that the diagnostic accuracy of miRNA, lncRNA and circRNA were not significantly different (p > 0.05). Circulating ncRNAs showed higher diagnostic accuracy for patients with unruptured IA than those with ruptured IA (p = 0.0122). CONCLUSION: Current evidence suggests that the circulating ncRNA test could be an effective method for universal IA screening. Future clinical studies need to confirm the diagnostic role of specific ncRNAs.


Subject(s)
Cell-Free Nucleic Acids/blood , Intracranial Aneurysm/diagnosis , RNA, Untranslated/blood , Adult , Aged , Biomarkers/blood , Cell-Free Nucleic Acids/genetics , Female , Humans , Intracranial Aneurysm/blood , Intracranial Aneurysm/genetics , Male , Middle Aged , Predictive Value of Tests , RNA, Untranslated/genetics
9.
Gene Expr ; 20(3): 179-188, 2021 06 11.
Article in English | MEDLINE | ID: mdl-33757622

ABSTRACT

Genomic and transcriptomic analyses have well established that the major fraction of the mammalian genome is transcribed into different classes of RNAs ranging in size from a few nucleotides to hundreds of thousands of nucleotides, which do not encode any protein. Some of these noncoding RNAs (ncRNAs) are directly or indirectly linked to the regulation of expression or functions of 25,000 proteins coded by <2% of the human genome. Among these regulatory RNAs, microRNAs are small (2125 nucleotides) RNAs that are processed from precursor RNAs that have stemloop structure, whereas noncoding RNAs >200 nucleotides are termed long noncoding RNAs (lncRNAs). Circular RNAs (circRNAs) are newly identified lncRNA members that are generated by back-splicing of primary transcripts. The functions of ncRNAs in modulating liver toxicity of xenobiotics are emerging only recently. Acetaminophen (N-acetyl-para-aminophenol, paracetamol or APAP) is a safe analgesic and antipyretic drug at the therapeutic dose. However, it can cause severe liver toxicity that may lead to liver failure if overdosed or combined with alcohol, herbs, or other xenobiotics. This review discusses the role of ncRNAs in acetaminophen metabolism, toxicity, and liver regeneration after APAP-induced liver injury (AILI).


Subject(s)
Acetaminophen/toxicity , Analgesics, Non-Narcotic/toxicity , Chemical and Drug Induced Liver Injury/metabolism , RNA, Untranslated/genetics , Animals , Chemical and Drug Induced Liver Injury/etiology , Chemical and Drug Induced Liver Injury/genetics , Cytochrome P450 Family 3/genetics , Cytochrome P450 Family 3/metabolism , Humans , RNA, Untranslated/blood , RNA, Untranslated/metabolism
10.
J Cardiovasc Transl Res ; 14(2): 213-221, 2021 04.
Article in English | MEDLINE | ID: mdl-32607873

ABSTRACT

The treatment and early outcome of patients with acute myocardial infarction (MI) have dramatically improved the past decades, but the incidence of left ventricular (LV) dysfunction post-MI remains high. Peripheral blood RNAs reflect pathophysiological changes during acute MI and the inflammatory process. Therefore, these RNAs are promising new markers to molecularly phenotype patients and improve the early identification of patients at risk of subsequent LV dysfunction. We here discuss the coding and long non-coding RNAs that can be measured in peripheral blood of patients with acute MI and list the advantages and limitations for implementation in clinical practice. Although some studies provide preliminary evidence of their diagnostic and prognostic potential, the use of these makers has not yet been implemented in clinical practice. The added value of RNAs to improve treatment and outcome remains to be determined in larger clinical studies. International consortia are now catalyzing renewed efforts to investigate novel RNAs that may improve post-MI outcome in a precision-medicine approach. Graphical Abstract Peripheral blood RNAs reflect the inflammatory changes in acute MI. A number of studies provide preliminary evidence of their prognostic potential, although the use of these makers has not yet been assessed in clinical practice.


Subject(s)
Myocardial Infarction/complications , RNA, Messenger/blood , RNA, Untranslated/blood , Translational Research, Biomedical , Ventricular Dysfunction, Left/etiology , Ventricular Function, Left , Animals , Biomarkers/blood , Clinical Decision-Making , Humans , Inflammation Mediators/blood , Myocardial Infarction/blood , Myocardial Infarction/genetics , Myocardial Infarction/physiopathology , Predictive Value of Tests , Prognosis , RNA, Messenger/genetics , RNA, Untranslated/genetics , Risk Assessment , Risk Factors , Ventricular Dysfunction, Left/blood , Ventricular Dysfunction, Left/genetics , Ventricular Dysfunction, Left/physiopathology
11.
Int J Mol Sci ; 21(23)2020 Dec 05.
Article in English | MEDLINE | ID: mdl-33291434

ABSTRACT

In 2020, cardiovascular diseases (CVDs) remain a leading cause of mortality and morbidity, contributing to the burden of the already overloaded health system. Late or incorrect diagnosis of patients with CVDs compromises treatment efficiency and patient's outcome. Diagnosis of CVDs could be facilitated by detection of blood-based biomarkers that reliably reflect the current condition of the heart. In the last decade, non-coding RNAs (ncRNAs) present on human biofluids including serum, plasma, and blood have been reported as potential biomarkers for CVDs. This paper reviews recent studies that focus on the use of ncRNAs as biomarkers of CVDs.


Subject(s)
Biomarkers , Cardiovascular Diseases/blood , Cardiovascular Diseases/diagnosis , Cell-Free Nucleic Acids , RNA, Untranslated/blood , Animals , Disease Management , Disease Susceptibility , Humans , Prognosis
12.
Dis Markers ; 2020: 8822859, 2020.
Article in English | MEDLINE | ID: mdl-33133304

ABSTRACT

Nonalcoholic fatty liver disease (NAFLD) is currently the most common chronic liver disease worldwide in part due to the concomitant obesity pandemic and insulin resistance (IR). It is increasingly becoming evident that NAFLD is a disease affecting numerous extrahepatic vital organs and regulatory pathways. The molecular mechanisms underlying the nonalcoholic steatosis formation are poorly understood, and little information is available on the pathways that are responsible for the progressive hepatocellular damage that follows lipid accumulation. Recently, much research has focused on the identification of the epigenetic modifications that contribute to NAFLD pathogenesis. Noncoding RNAs (ncRNAs) are one of such epigenetic factors that could be implicated in the NAFLD development and progression. In this review, we summarize the current knowledge of the genetic and epigenetic factors potentially underlying the disease. Particular emphasis will be put on the contribution of microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs) to the pathophysiology of NAFLD as well as their potential use as therapeutic targets or as markers for the prediction and the progression of the disease.


Subject(s)
Non-alcoholic Fatty Liver Disease/genetics , RNA, Untranslated/genetics , Biomarkers , Epigenesis, Genetic , Humans , Non-alcoholic Fatty Liver Disease/diagnosis , Non-alcoholic Fatty Liver Disease/mortality , Non-alcoholic Fatty Liver Disease/physiopathology , Prognosis , RNA, Untranslated/blood
13.
Aging (Albany NY) ; 12(22): 23047-23066, 2020 11 21.
Article in English | MEDLINE | ID: mdl-33234723

ABSTRACT

Carcinoembryonic antigen (CEA) is the most significant plasma biomarker in colorectal cancer (CRC), which is mainly used to diagnose and monitor the recurrence of CRC. However, due to the low sensitivity of CEA, it is more recommended for postoperative surveillance rather than early diagnosis. It is necessary to find efficient biomarkers for CRC. In this study, the expression of plasma non-coding RNAs was confirmed in three independent cohorts with total 1201 participants. First, 12 non-coding RNAs were screened from 9 plasma samples by using microarray. The expression of selected non-coding RNAs was further validated by multiphase detection and risk score analysis. We found that miR-20b-5p, miR-329-3p, miR-374b-5p, miR-503-5p, XLOC_001120 and ENSG00000243766.2 were significantly elevated in CRC plasma, and the AUC in training and validation set was 0.996 and 0.954, respectively. Moreover, miR-20b-5p, miR-329-3p and miR-503-5p were found elevated in plasma from larger tumors (5 cm as the cutoff) in CRC patients, and the merged AUC in training and validation set was 0.896 and 0.881. In conclusion, a panel of 6 non-coding RNAs showed their important clinical value for the early diagnosis of CRC. Among, miR-20b-5p, miR-329-3p and miR-503-5p might be the potential markers for evaluating larger tumor size of CRC.


Subject(s)
Carcinogenesis/pathology , Colorectal Neoplasms/blood , Colorectal Neoplasms/diagnosis , RNA, Untranslated/blood , Biomarkers, Tumor/blood , Colorectal Neoplasms/pathology , Female , Gene Expression Regulation, Neoplastic , Humans , Male , MicroRNAs/metabolism , Microarray Analysis , Middle Aged , Sensitivity and Specificity
14.
Int J Mol Sci ; 21(20)2020 Oct 15.
Article in English | MEDLINE | ID: mdl-33076555

ABSTRACT

Alzheimer's disease (AD) diagnosis is actually based on clinical evaluation and brain-imaging tests, and it can often be confirmed only post-mortem. Therefore, new non-invasive molecular biomarkers are necessary to improve AD diagnosis. As circulating microRNA biomarkers have been proposed for many diseases, including AD, we aimed to identify new diagnostic non-small RNAs in AD. Whole transcriptome analysis was performed on plasma samples of five AD and five unaffected individuals (CTRL) using the Clariom D Pico Assay, followed by validation in real-time PCR on 37 AD patients and 37 CTRL. Six differentially expressed (DE) transcripts were identified: GS1-304P7.3 (upregulated), NONHSAT090268, TC0100011037, TC0400008478, TC1400008125, and UBE2V1 (downregulated). Peripheral blood mononuclear cells (PBMCs) may influence the expression of circulating RNAs and their analysis has been proposed to improve AD clinical management. Accordingly, DE transcript expression was also evaluated in PBMCs, showing no difference between AD and CTRL. ROC (receiver operating characteristic) curve analysis was performed to evaluate the diagnostic accuracy of each DE transcript and a signature including all of them. A correlation between cognitive impairment and GS1-304P7.3, NONHSAT090268, TC0100011037, and TC0400008478 was detected, suggesting a potential association between their extracellular abundance and AD clinical phenotype. Finally, this study identified six transcripts showing altered expression in the plasma of AD patients. Given the need for new, accurate blood biomarkers for AD diagnosis, these transcripts may be considered for further analyses in larger cohorts, also in combination with other biomarkers, aiming to identify specific RNA-based biomarkers to be eventually applied to clinical practice.


Subject(s)
Alzheimer Disease/blood , Cell-Free Nucleic Acids/blood , Cognition , RNA, Untranslated/blood , Aged , Aged, 80 and over , Alzheimer Disease/diagnosis , Biomarkers/blood , Female , Humans , Male , Transcriptome
15.
DNA Cell Biol ; 39(11): 1938-1947, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32991198

ABSTRACT

Circular RNAs (circRNAs), a novel group of noncoding RNAs, are present in most eukaryotic cells. Different from messenger RNAs, circRNAs have a covalently closed single-stranded stable structure and often act in cell type and tissue-specific manners, indicating that they can be used as biomarkers. With the advance of high-throughput RNA sequencing technology and bioinformatics, a large number of circRNAs have been identified in association with musculoskeletal diseases, but the functions of most circRNAs have not been clarified. circRNAs regulate biological processes by adsorbing microRNA as "sponges," binding to proteins, acting as transcriptional regulators, and participating in translation of proteins. In this study, we discuss the latest understanding of biogenesis and gene regulatory mechanisms of circRNAs with special emphasis on new targets for musculoskeletal disease diagnosis and clinical treatment.


Subject(s)
Biomarkers/blood , Musculoskeletal Diseases/blood , RNA, Circular/blood , Biomarkers/metabolism , Computational Biology , Gene Expression Regulation/genetics , Humans , Musculoskeletal Diseases/genetics , Musculoskeletal Diseases/pathology , RNA, Circular/genetics , RNA, Messenger/genetics , RNA, Untranslated/blood , RNA, Untranslated/genetics
16.
Int J Mol Sci ; 21(11)2020 Jun 11.
Article in English | MEDLINE | ID: mdl-32545342

ABSTRACT

In the recent years, the prevalence of metabolic conditions such as type 2 Diabetes (T2D) and metabolic syndrome (MetS) raises. The impairment of liver metabolism resulting in hepatic insulin resistance is a common symptom and a critical step in the development of T2D and MetS. The liver plays a crucial role in maintaining glucose homeostasis. Hepatic insulin resistance can often be identified before other symptoms arrive; therefore, establishing methods for its early diagnosis would allow for the implementation of proper treatment in patients before the disease develops. Non-coding RNAs such as miRNAs (micro-RNA) and lncRNAs (long-non-coding RNA) are being recognized as promising novel biomarkers and therapeutic targets-especially due to their regulatory function. The dysregulation of miRNA and lncRNA activity has been reported in the livers of insulin-resistant patients. Many of those transcripts are involved in the regulation of the hepatic insulin signaling cascade. Furthermore, for several miRNAs (miR-802, miR-499-5p, and miR-122) and lncRNAs (H19 imprinted maternally expressed transcript (H19), maternally expressed gene 3 (MEG3), and metastasis associated lung adenocarcinoma transcript 1 (MALAT1)), circulating levels were altered in patients with prediabetes, T2D, and MetS. In the course of this review, the role of the aforementioned ncRNAs in hepatic insulin signaling cascade, as well as their potential application in diagnostics, is discussed. Overall, circulating ncRNAs are precise indicators of hepatic insulin resistance in the development of metabolic diseases and could be applied as early diagnostic and/or therapeutic tools in conditions associated with insulin resistance.


Subject(s)
Biomarkers/blood , Insulin Resistance/genetics , Liver/metabolism , RNA, Untranslated/blood , Biomarkers/analysis , Humans , Insulin/genetics , Insulin/metabolism , MicroRNAs/blood , MicroRNAs/genetics , RNA, Long Noncoding/blood , RNA, Long Noncoding/genetics
17.
Int J Mol Sci ; 21(10)2020 May 25.
Article in English | MEDLINE | ID: mdl-32466222

ABSTRACT

In the era of single-cell analysis, one always has to keep in mind the systemic nature of various diseases and how these diseases could be optimally studied. Comorbidities of the heart in neurological diseases as well as of the brain in cardiovascular diseases are prevalent, but how interactions in the brain-heart axis affect disease development and progression has been poorly addressed. Several brain and heart diseases share common risk factors. A better understanding of the brain-heart interactions will provide better insights for future treatment and personalization of healthcare, for heart failure patients' benefit notably. We review here emerging evidence that studying noncoding RNAs in the brain-heart axis could be pivotal in understanding these interactions. We also introduce the Special Issue of the International Journal of Molecular Sciences RNAs in Brain and Heart Diseases-EU-CardioRNA COST Action.


Subject(s)
Brain Diseases/metabolism , Cell-Free Nucleic Acids/metabolism , Heart Diseases/metabolism , RNA, Untranslated/metabolism , Animals , Biomarkers/blood , Brain Diseases/blood , Cell-Free Nucleic Acids/blood , Heart Diseases/blood , Humans , RNA, Untranslated/blood , Signal Transduction
18.
Biomed Res Int ; 2020: 3298696, 2020.
Article in English | MEDLINE | ID: mdl-32337239

ABSTRACT

Acute coronary syndrome (ACS), consisting of acute myocardial infarction and unstable angina, is the most dangerous and fatal form of coronary heart disease. Acute coronary syndrome has sudden onset and rapid development, which may lead to malignant life-threatening conditions at any time. Therefore, early detection and diagnosis are critical for patients with ACS. Recent studies have found that noncoding RNA is of great significance in the diagnosis and treatment of cardiovascular diseases. In this review, we summarized recent data on circulating noncoding RNAs (including microRNA, long noncoding RNA, and circular RNA) as diagnostic and prognostic markers in ACS including acute myocardial infarction and unstable angina. Specifically, microRNAs (miRNAs) as diagnostic markers are divided into three types: miRNAs of increased expression in ACS, miRNAs of decreased expression in ACS, and miRNAs of contradictory expression in ACS. Moreover, we described these miRNAs of increased expression in ACS based on miRNAs family. This review may result in a great guidance of noncoding RNAs as biomarkers for ACS in clinical practice.


Subject(s)
Acute Coronary Syndrome , Biomarkers/blood , RNA, Untranslated/blood , Acute Coronary Syndrome/diagnosis , Acute Coronary Syndrome/epidemiology , Acute Coronary Syndrome/metabolism , Humans , Prognosis
19.
Adv Exp Med Biol ; 1229: 357-367, 2020.
Article in English | MEDLINE | ID: mdl-32285424

ABSTRACT

The discovery of noncoding RNAs (ncRNAs) including short microRNAs, long ncRNAs and circular RNAs has broaden our knowledge about mammalian genomes and transcriptomes. A growing number of evidence on aberrantly regulated ncRNAs in cardiovascular diseases has indicated that ncRNAs are critical contributors to cardiovascular pathophysiology. Moreover, multiple recent studies have reported that ncRNAs can be detected in the bloodstream that differs between health subjects and diseased patients and some of them are remarkably stable. Although our knowledge about the origin and function of the circulating ncRNAs is still limited, these molecules have been regarded as promising noninvasive biomarker for risk stratification, diagnosis and prognosis of various cardiovascular diseases. In this chapter, we have described biological characteristics of circulating ncRNAs and discussed current trends and future prospects for the usage of circulating ncRNAs as biomarkers for common cardiovascular diseases.


Subject(s)
Cardiovascular Diseases/blood , Cardiovascular Diseases/genetics , RNA, Untranslated/blood , Animals , Biomarkers/blood , Humans , MicroRNAs/blood , RNA, Long Noncoding/blood
20.
Proc Natl Acad Sci U S A ; 117(16): 9042-9053, 2020 04 21.
Article in English | MEDLINE | ID: mdl-32241891

ABSTRACT

RNA has been proposed as an important scaffolding factor in the nucleus, aiding protein complex assembly in the dense intracellular milieu. Architectural contributions of RNA to cytosolic signaling pathways, however, remain largely unknown. Here, we devised a multidimensional gradient approach, which systematically locates RNA components within cellular protein networks. Among a subset of noncoding RNAs (ncRNAs) cosedimenting with the ubiquitin-proteasome system, our approach unveiled ncRNA MaIL1 as a critical structural component of the Toll-like receptor 4 (TLR4) immune signal transduction pathway. RNA affinity antisense purification-mass spectrometry (RAP-MS) revealed MaIL1 binding to optineurin (OPTN), a ubiquitin-adapter platforming TBK1 kinase. MaIL1 binding stabilized OPTN, and consequently, loss of MaIL1 blunted OPTN aggregation, TBK1-dependent IRF3 phosphorylation, and type I interferon (IFN) gene transcription downstream of TLR4. MaIL1 expression was elevated in patients with active pulmonary infection and was highly correlated with IFN levels in bronchoalveolar lavage fluid. Our study uncovers MaIL1 as an integral RNA component of the TLR4-TRIF pathway and predicts further RNAs to be required for assembly and progression of cytosolic signaling networks in mammalian cells.


Subject(s)
Cell Cycle Proteins/metabolism , Interferon Type I/genetics , Membrane Transport Proteins/metabolism , RNA, Untranslated/metabolism , Respiratory Tract Infections/immunology , Toll-Like Receptor 4/metabolism , Adaptor Proteins, Vesicular Transport/metabolism , Adult , Aged , Blood Buffy Coat/cytology , Bronchoalveolar Lavage Fluid/immunology , Female , Gene Expression Regulation/immunology , Gene Knockdown Techniques , Humans , Interferon Regulatory Factor-3/metabolism , Interferon Type I/blood , Interferon Type I/immunology , Macrophages , Male , Middle Aged , Phosphorylation/genetics , Primary Cell Culture , Protein Serine-Threonine Kinases/metabolism , Protein Stability , RNA, Untranslated/blood , RNA, Untranslated/genetics , RNA-Seq , Respiratory Tract Infections/blood , Respiratory Tract Infections/microbiology , Signal Transduction/genetics , Signal Transduction/immunology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...